Memorial Sloan Kettering hematologic oncologist C. Ola Landgren

C. Ola Landgren, MD, PhD

Hematologic Oncologist


Chief, Myeloma Service

Clinical Expertise

Multiple Myeloma; Smoldering Myeloma; Monoclonal Gammopathy of Undetermined Significance (MGUS); Related Plasma Cell Disorders

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Landgren accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me


MD, Karolinska Institutet


Nykoping Hospital (Sweden)


Hematology/Internal Medicine - Karolinska University Hospital; Medicine - National Cancer Institute

Board Certifications

Hematology; Internal Medicine

I am a board-certified hematologist-oncologist whose research focuses on the development of novel treatment strategies and advanced disease monitoring by new minimal residual disease (MRD) assays, as well as biological studies focusing on disease and host biology. I also study mechanism and markers of progression from MGUS/smoldering myeloma to symptomatic multiple myeloma, and the identification of high-risk precursor patients who may be candidates for early treatment. I have a strong interest in the development of early-treatment clinical trials targeting high-risk smoldering myeloma.

I am one of the pioneers in the development of MRD testing in myeloma. In collaboration with colleagues at MSK as well nationally/internationally, I develop new strategies (including cell-based, molecular-based, and imaging-based) and implement advanced MRD testing in clinical trials at MSK.

I am involved in the service’s rational treatment program (small molecule, monoclonal antibody, immune-based) for newly diagnosed, relapsed and refractory myeloma and amyloidosis patients.

In addition, I lead the development of a structured program for the education and mentoring of residents and fellows in the Myeloma Service. The service also takes part in regular multi-disciplinary clinical conferences and scientific meetings.

I am also fluent in English, Swedish and German.


Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Landgren’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.